Gregory J Pelka Selected Research

Rett Syndrome (Rett's Disorder)

2/2016	Affective dysfunction in a mouse model of Rett syndrome: Therapeutic effects of environmental stimulation and physical activity.
9/2015	Deletion of protein tyrosine phosphatase, non-receptor type 4 (PTPN4) in twins with a Rett syndrome-like phenotype.
11/2013	Chromatin context and ncRNA highlight targets of MeCP2 in brain.
2/2012	A novel transcript of cyclin-dependent kinase-like 5 (CDKL5) has an alternative C-terminus and is the predominant transcript in brain.
6/2008	Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome--Mecp2 gene dosage effects and BDNF expression.
7/2005	Reduced proportion of Purkinje cells expressing paternally derived mutant Mecp2308 allele in female mouse cerebellum is not due to a skewed primary pattern of X-chromosome inactivation.
12/2004	Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gregory J Pelka Research Topics

Disease

7	Rett Syndrome (Rett's Disorder) 02/2016 - 12/2004
3	Neurodevelopmental Disorders 02/2016 - 12/2004
1	Infantile Spasms (West Syndrome) 02/2012
1	Seizures (Absence Seizure) 02/2012

Drug/Important Bio-Agent (IBA)

4	Methyl-CpG-Binding Protein 2IBA 02/2016 - 12/2004
1	Therapeutic UsesIBA 02/2016
1	Non-Receptor Type 4 Protein Tyrosine PhosphataseIBA 09/2015
1	Carrier Proteins (Binding Protein)IBA 11/2013
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 02/2012

Therapy/Procedure

1	Therapeutics 02/2016